Abstract
Antibodies engineered in their variable domain to express epitopes of heterologous antigens—antigenized antibodies—function as immunogens. Only the third complementarity-determining region (CDR3) of the H chain has been used as the site of epitope expression, as this loop has the highest natural variability in length and amino acid composition. We demonstrate that the CDR2 can be engineered to express a 12–amino acid peptide, which is a T-cell determinant that enhances the response to a B-cell eprtope peptide of Plasmodium falciparum expressed in the CDR3 of the same variable domain. Mice with this gene inoculated into the spleen mounted an antibody response against the B-cell eprtope higher than mice receiving the gene coding for the B-cell eprtope only. In vitro studies established that the two epitopes were independently immunogenic in vivo.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Zanetti, M. 1992. Antigenized antibodies. A/aft/re 355: 466–477.
Zanetti, M., Rossi, F., Lanza, P., Filaci, G., Lee, R.H., and Billetta, R. 1992. Theoretical and practical aspects of antigenized antibodies. Immunol. Rev. 130: 125–150.
Sollazzo, M., Billetta, R., and Zanetti, M. 1990. Expression of an exogenous pep-tide epitope genetically engineered in the variable domain of an immunoglobulin: implications for antibody and peptide folding. Prot. Engineer. 4: 215–220.
Billetta, R., Hollingdale, R.M., and Zanetti, M. 1991. Immunogenicity of an engineered internal image antibody. Proc. Natl. Acad. Sci. USA 88: 4713–4717.
Lanza, P., Billetta, R., Antonenko, S., and Zanetti, M. 1993. Active immunity against the CD4 receptor using an antibody antigenized with residues 41-55 of the first extracellular domain. Proc. Natl. Acad. Sci. USA 90: 11683–11687.
Zaghouani, H., Anderson, S.A., Sperber, K.E., Daian, C., Kennedy, R.C., Mayer, L., and Bona, C.A. 1995. Induction of antibodies to the human immunodeficiency virus type 1 by immunization of baboons with immunoglobulin molecules carrying the principal neutralizing determinant of the envelope protein. Proc. Natl. Acad. Sci. USA 92: 631–635.
Zaghouani, H., Steinman, R., Nonacs, R., Shah, H., Gerhard, W., and Bona, C. 1993. Presentation of a viral I cell epitope expressed in the CDR3 region of a self immunoglobulin molecule. Science 259: 224–227.
Billetta, R., Filaci, G., and Zanetti, M. 1995. Major histocompatibilrty complex class I-restricted presentation of influenza virus nucleoprotein peptide by B lymphoma cells harboring an antibody gene antigenized with the virus peptide. Eur. J. Immunol. 25: 776–783.
Xiong, S., Gerloni, M., and Zanetti, M. 1997. In vivo role of B lymphocytes in somatic transgene immunization. Proc. Natl. Acad. Sci. USA 94: 6352–6357.
Gerloni, M., Billetta, R., Xiong, S., and Zanetti, M. 1997. Somatic transgene immunization with DMA encoding an immunoglobulin heavy chain. DNA Cell. Biol. 16: 611–625.
Gerloni, M., Ballou, W.R., Billetta, R., and Zanetti, M. 1997. Immunity to Plasmodium falciparum sporozoites by somatic transgene immunization. Nature Biotechnology 15: 876–881.
Ulmer, J.B., Donnelly, J.J., Parker, S.E., Rhodes, G.H., Feigner, R.L., Dwarki, V.J., et al. 1993. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259: 1745–1749.
Wang, B., Ugen, K., Srikantan, V., Agadjanyan, M., Dang, K., Refaeli, Y., et al. 1993. Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 90: 4156–4160.
Raz, E., Carson, D.A., Parker, S.E., Parr, T.B., Abai, A.M., Aichinger, G., et al. 1994. Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc. Natl. Acad. Sci. USA 91: 9519–9523.
Sedegah, M., Hedstrom, R., Hobart, R., and Hoffman, S.L. 1994. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc. Natl. Acad. Sci. USA 91: 9866–9870.
Davis, H.L., Michel, M.L., Mancini, M., Schleef, M., and Whalen, R.G. 1994. Direct gene transfer in skeletal muscle: plasmid DNA-based immunization against the hepatitis B virus surface antigen. Vaccine 12: 1503–1509.
Conry, R.M., LoBuglio, A.F., Kantor, J., Schlom, J., Loechel, R., Moore, S.E., et al. 1994. Immune response to a carcinoembryonic antigen polynucleotide vaccine. Cancer Res. 54: 1164–1168.
Fynan, E.F., Webster, R.G., Fuller, D.H., Haynes, J.R., Santoro, J.C., and Robinson, H.L. 1993. DNA vaccines: protectivce immunizations by parenteral, mucosal and gene-gun inoculations. Proc. Natl. Acad. Sci. USA 90: 11478–11482.
Eisenbraun, M.D., Fuller, D.H., and Haynes, J.R. 1993. Examination of parameters affecting the elicitation of humoral immune responses by particle bombardment-mediated genetic immunization. DNA Cell Biol. 12: 791–797.
Mitchison, N.A. 1971. The carrier effect in the secondary response to hapten-protein conjugates. II. Cellular cooperation. Eur. J. Immunol. 1: 18–27.
Herrington, D.A., Clyde, D.F., Losonsky, G., Cortesia, M., Murphy, J.R., Davis, J., et al. 1987. Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparumsporozoites. Nature 328: 257–259.
Tarn, J.P. and Lu, Y.A. 1989. Vaccine engineering: enhancement of immunogenicity of synthetic peptide vaccines related to hepatitis in chemically defined models consisting of T- and B-cell epitopes. Proc. Natl. Acad. Sci. USA 86: 9084–9088.
Tarn, J.P., Clavijo, P., Lu, Y.A., Nussenzweig, V., Nussenzweig, R.S., and Zavala, F. 1990. Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria. J. Exp. Med. 171: 299–306.
Munesinghe, D.Y., Clavijo, P., Calle, M.C., Nussenzweig, R.S., and Nardin, E. 1991. Immunogenicity of multiple antigen peptides (MAP) containing T and B cell epitopes of the repeat region of the P. falciparum circumsporozoite protein. Eur. J. Immunol. 21: 3015–3020.
Ballou, W.R., Hoffman, S.L., Sherwood, J.A., Hollingdale, M.R., Neva, F.A., Hockmeyer, W.T., et al. 1987. Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccine. Lancet 1: 1277–1281.
Herrington, D.A., Losonsky, G.A., Smith, G., Volvovitz, F., Cochran, M., Jackson, K., et al. 1992. Safety and immunogenicity in volunteers of a recombinant Plasmodium falciparum circumsporozoite protein malaria vaccine produced in Lepidopteran cells. Vaccine 10: 841–846.
Zavala, R., Tam, J.P., Hollingdale, M.R., Cochrane, A.H., Quakyi, I., Nussenzweig, R.S., and Nussenzweig, V. 1985. Rationale for development of a synthetic vaccine against Plasmodium falciparum malaria. Science 228: 1436–1440.
Nardin, E.H., Herrington, D.A., Davis, J., Levine, M., Stuber, D., Takacs, B., et al. 1989. Conserved repetitive epitope recognized by CD4+ clones from a malaria-immunized volunteer. Science 246: 1603–1606.
Sollazzo, M., Castiglia, D., Billetta, R., Tramontano, A., and Zanetti, M. 1990. Structural definition by antibody engineering of an idiotypic determinant. Prot. Engineer. 3: 531–539.
Rigaudy, R., Simon, S., Hunter, T., Sollazzo, M., Billetta, R., Zanetti, M., et al. 1994. Antibodies specific for the neuronal form of the scr protein elicited by an antigenized antibody. DNA Cell Biol. 13: 585–591.
Morrison, S. 1985. Transfectomas provide novel chimeric antibodies. Science 229: 1202–1207.
Billetta, R. and Zanetti, M. 1992. Ligand expression using antigenization of antibody: Principle and methods. ImmunoMethods 1: 41–51.
Togna, A.R., Del, G.G., Verdini, A.S., Bonelli, F., Pessi, A., Engers, H.D., and Corradin, G., 1986. Plasmodium falciparum circumsporozoite peptides elicit heteroge-nous L3T4+ T cell proliferative responses in H-2b mice. J. Immunol. 137: 2956–2960.
Alzari, P.M., Lacombe, M.-B., and Poljak, R.J. 1988. Three-dimensional structure of antibodies. Ann. Rev. Immunol. 6: 555–580.
Kabat, E.A., Wu, E.T., Reidmilter, M., Perry, H.M., and Gottesman, K.S. 1987. Proteins of immunological interest. U.S. Department of (Health and Human Services, Bethesda, MD.
Chothia, C., Lesk, A.M., Tramontane, A., Levitt, M., Smith-Gill, S.J., Air, G., et al. 1989. Conformations of immunoglobulin hypervariable regions. Nature 342: 877–883.
Chothia, C. and Lesk, A.M. 1987. Canonical structures for the hypervariable regions of immunoglobulins. J. Mol. Biol. 196: 901–917.
Poljak, R.J., Amzel, L.M., Avey, H.R., Chen, B.L., Phizackerly, R.R., and Saul, F. 1973. Three-dimensional structure of the Fab' fragment of a human immunoglobulin at 2. 8 A resolution. Proc. Natl. Acad. Sci. USA. 70: 3305–3310.
Sollazzo, M., Hasemann, C.A., Meek, K.D., Glotz, D., Capra, J.D., and Zanetti, M. 1989. Molecular characterization of the VH region of murine autoantibodies from neonatal and adult BALB/c mice. Eur. J. Immunol. 19: 453–457.
Towbin, H., Staehelin, T., and Gordon, J. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc. Natl. Acad. Sci. USA 76: 4350–4354.
Sambrook, J., Fritsch, E.F., and Maniatis, T. 1989. Molecular cloning: a laboratory manual, 8th ed.Cold Spring Harbor Laboratory Press, Cold Spring, NY.
Glasel, J.A. 1995. Validity of nucleic acid purities monitored by 260nm/280nm absorbance ratios. BioTechniques 18: 62–63.
Bradley, L.M., Duncan, D.D., Yoshimoto, K., and Swain, S.L. 1993. Memory effectors: a potent, IL-4-secreting helper T cell population that develops in vivo after restimulation with antigen. J. Immunol. 150: 3119–3130.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Xiong, S., Gerloni, M. & Zanetti, M. Engineering vaccines with heterologous B and T cell epitopes using immunoglobulin genes. Nat Biotechnol 15, 882–886 (1997). https://doi.org/10.1038/nbt0997-882
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nbt0997-882
This article is cited by
-
Spontaneous transgenesis of human B lymphocytes
Gene Therapy (2004)
-
Antibodies engineered with IgD specificity efficiently deliver integrated T-cell epitopes for antigen presentation by B cells
Nature Biotechnology (1999)
-
Elegantly presented DNA vaccines
Nature Biotechnology (1997)
-
Immunity to Plasmodium falciparum malaria sporozoites by somatic transgene immunization
Nature Biotechnology (1997)